» Articles » PMID: 30388617

Targeting Long Noncoding RNA in Glioma: A Pathway Perspective

Overview
Publisher Cell Press
Date 2018 Nov 3
PMID 30388617
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) participate extensively in biological processes of various cancers. The majority of these transcripts are uniquely expressed in differentiated tissues or specific cancer types. lncRNAs are aberrantly expressed in gliomas and exert diverse functions. In this article, we provided an overview of how lncRNAs regulate cellular processes in glioma, enumerated the lncRNAs that may act as glioma biomarkers, and showed their potential clinical implications.

Citing Articles

Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine.

Prakash V, Gabrani R Neurogenetics. 2024; 26(1):5.

PMID: 39585441 DOI: 10.1007/s10048-024-00793-5.


Long Non-Coding RNA and as a Promising Diagnostic and Prognostic Biomarker in Glioblastoma Multiforme.

Poursheikhani A, Mosallaei M, Heidari M, Rajaeinejad M, Chamanara M, Zoshk M Iran J Public Health. 2024; 53(9):2090-2102.

PMID: 39429673 PMC: 11490338. DOI: 10.18502/ijph.v53i9.16462.


Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets.

Jiang C, Zhang J, Wang W, Shan Z, Sun F, Tan Y Front Physiol. 2023; 14:1158839.

PMID: 37664422 PMC: 10469264. DOI: 10.3389/fphys.2023.1158839.


LncRNA WEE2-AS1 knockdown inhibits the proliferation, migration and invasion of glioma cells via regulating miR-29b-2-5p/TPM3 axis.

Jia Z, Qian Z, Tang Y, Li X, Shi Y, Xin H Oncol Res. 2023; 29(2):105-117.

PMID: 37305396 PMC: 10207975. DOI: 10.32604/or.2022.03536.


LncRNA CASC2 Inhibits Progression of Glioblastoma by Regulating the Expression of AKT in T98G Cell Line, Treated by TMZ and Thiosemicarbazone Complex.

Shahmir S, Zahmatkesh N, Mirzaahmadi S, Asaadi Tehrani G Asian Pac J Cancer Prev. 2023; 24(5):1553-1560.

PMID: 37247274 PMC: 10495874. DOI: 10.31557/APJCP.2023.24.5.1553.


References
1.
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi Z . Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget. 2014; 6(1):537-46. PMC: 4381613. DOI: 10.18632/oncotarget.2681. View

2.
Guo J, Cai H, Zheng J, Liu X, Liu Y, Ma J . Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(9):2240-2254. DOI: 10.1016/j.bbadis.2017.02.005. View

3.
Matsui M, Corey D . Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2016; 16(3):167-179. PMC: 5831170. DOI: 10.1038/nrd.2016.117. View

4.
Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

5.
Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G . LncRNA-XIST interacts with to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Biosci Rep. 2017; 37(5). PMC: 5587918. DOI: 10.1042/BSR20170696. View